Abstract:The inactive conformations of glucagon receptor (GCGR) are widely reported by crystal structures that support the precision structure for drug discovery of type 2 diabetes. The previous study shows that the intracellular part is open in the glucagon-bound GCGR (glu-GCGR) and closed in the apo-GCGR by accelerated molecular dynamics (aMD) simulations. However, the crystal structure of GCGR in complex with partial agonist shows that the intracellular part is closed in the inactive conformation. To understand the differences between the studies of aMD simulations and crystal structure, the 2,500 ns conventional molecular dynamics (cMD) simulations are performed on the simulated model of glu-GCGR. The result shows that the transmembrane helices (TMH) 6 of glu-GCGR is outward ~4 Å to drive the intracellular part of glu-GCGR open until ~390 ns cMD simulations. The (TMH) 6 of glu-GCGR becomes closed after ~490 ns cMD simulations, which are consistent with the crystal structure of GCGR in complex with the partial agonist. To further elucidate the activation mechanism of GCGR deeply, the simulated models of glu-GCGR, apo-GCGR, and antagonist-bound GCGR (ant-GCGR) are constructed to perform 10 of parallel 300 ns aMD simulations, respectively. The results show that both of glu-GCGR and apo-GCGR can generate the open conformations of the intracellular part. But the glu-GCGR has the higher percentage of open conformations than apo-GCGR. The ant-GCGR is restricted to generate the open conformations of the intracellular part by antagonist MK-0893. It indicates that the glu-GCGR, apo-GCGR, and ant-GCGR can be distinguished by the aMD simulated method. Free energy landscape shows that the open conformations of the intracellular part of GCGR are in intermediate state. Our results show that aMD simulations enhance the space samplings of open conformations of GCGR via adding extra boost potential. It indicates that the aMD simulations are an effective way for drug discovery of GCGR.

Conformational states of the full-length glucagon receptor.

Structure of the full-length glucagon class B G-protein-coupled receptor

Activation And Conformational Dynamics Of A Class B G-Protein-Coupled Glucagon Receptor

Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor

Structure of the glucagon receptor in complex with a glucagon analogue

Conformation Transition of Intracellular Part of Glucagon Receptor in Complex with Agonist Glucagon by Conventional and Accelerated Molecular Dynamics Simulations.

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Selective Polypeptide Ligand Binding to the Extracellular Surface of the Transmembrane Domains of the Class B GPCRs GLP-1R and GCGR

Computational Insight Into Conformational States Of Glucagon-Like Peptide-1 Receptor (Glp-1r) And Its Binding Mode With Glp-1

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Investigation of ECD Conformational Transition Mechanism of GLP-1R by Molecular Dynamics Simulations and Markov State Model.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Phase-plate Cryo-Em Structure of a Class B GPCR–G-protein Complex

Full-length human GLP-1 receptor structure without orthosteric ligands

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Conformational Dynamics of the Activated GLP-1 Receptor-Gs Complex Revealed by Cross-Linking Mass Spectrometry and Integrative Structure Modeling.

Conformational Dynamics of the Activated GLP-1 Receptor-G s Complex Revealed by Cross-Linking Mass Spectrometry and Integrative Structure Modeling

Structural Basis for Activation of the Growth Hormone-Releasing Hormone Receptor.

Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

A combined activation mechanism for the glucagon receptor